-
cds.ahrq.gov/sites/default/files/workgroups/231/apr-2017-cholesterol-wg-notes.docx
January 01, 2017 - .
· Inpatient DVT prophylaxis efforts and eCQMs may have compiled bleeding disorder specifications. … this is not indicated for individuals at high risk of bleeding (as outlined in the exclusion logic)”
· Anticoagulants
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/2023_CDS_Connect_IG_Aspirin_Therapy.pdf
January 01, 2023 - Patient is on another anticoagulant.
f. Patient has allergy or intolerance to aspirin.
g. … alanine transaminase (ALT) result is > 150
OR diagnosis of thrombocytopenia
OR currently receiving an anticoagulant … OR “other medical condition”
OR use of medications that increase bleeding risk:
Concurrent use of anticoagulant … This new guideline changes
the inclusion age range to 40 – 59; the CVD prophylaxis recommendations to
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/2024_CDS_Connect_IG_Aspirin_Therapy.pdf
January 01, 2024 - Patient is on another anticoagulant.
6
f. Patient has allergy or intolerance to aspirin.
g. … alanine transaminase (ALT) result is >150
OR diagnosis of thrombocytopenia
OR currently receiving an anticoagulant … OR “other medical condition”
OR use of medications that increase bleeding risk:
Concurrent use of anticoagulant … This new guideline changes
the inclusion age range to 40 – 59; the CVD prophylaxis recommendations to